Slowly Progressive, Angiotensin II–Independent Glomerulosclerosis in Human (Pro)renin Receptor–Transgenic Rats
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
For defining the pathogenic effects of the (pro)renin receptor-transgenic rat, strains that overexpressed the human receptor were generated. Although transgenic rats were normotensive and euglycemic and had a renal angiotensin II (AngII) level that was comparable to that of wild-type rats, transgenic rats developed proteinuria with aging and significant glomerulosclerosis at 28 wk of age. In kidneys of 28-wk-old transgenic rats, mitogen-activated protein kinases (MAPK) were activated without recognizable tyrosine phosphorylation of the EGF receptor, and expression of TGF-beta1 was enhanced. In vivo infusion of the (pro)renin receptor blocker peptide (formerly handle region decoy peptide) significantly inhibited the development of glomerulosclerosis, proteinuria, MAPK activation, and TGF-beta1 expression in the kidneys, but the angiotensin-converting enzyme inhibitor did not attenuate these changes despite a significant decrease in the renal AngII level. In addition, recombinant rat prorenin stimulated MAPK activation in the human receptor-expressed cultured cells, but human receptor was unable to evoke the enzyme activity of rat prorenin. Thus, human (pro)renin receptor elicits slowly progressive nephropathy by AngII-independent MAPK activation in rats. This study clearly provided in vivo evidence for the AngII-independent MAPK activation by human (pro)renin receptor and induction of glomerulosclerosis with increased TGF-beta1 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Hitoshi, N., Ken-ichi, Y., & Jun-ichi, M. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,134
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276
Ichihara, A., Hayashi, M., Kaneshiro, Y., Suzuki, F., Nakagawa, T., Tada, Y., Koura, Y., Nishiyama, A., Okada, H., Uddin, M. N., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421398 · Cited by 456
Self-citationHuang, Y., Wongamorntham, S., Kasting, J., McQuillan, D., Owens, R. T., Yu, L., Noble, N. A., & Border, W. (2006) · Kidney International · doi:10.1038/sj.ki.5000011 · Cited by 423
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach
Lautrette, A., Li, S., Alili, R., Sunnarborg, S. W., Burtin, M., Lee, D. C., Friedlander, G., & Terzi, F. (2005) · Nature Medicine · doi:10.1038/nm1275 · Cited by 343
Ichihara, A., Suzuki, F., Nakagawa, T., Kaneshiro, Y., Takemitsu, T., Sakoda, M., Nabi, A. H. M. N., Nishiyama, A., Sugaya, T., Hayashi, M., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010029 · Cited by 284
Self-citationIchihara, A., Kaneshiro, Y., Takemitsu, T., Sakoda, M., Suzuki, F., Nakagawa, T., Nishiyama, A., Inagami, T., & Hayashi, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000215838.48170.0b · Cited by 264
Self-citationElevated Blood Pressure and Heart Rate in Human Renin Receptor Transgenic Rats
Burcklé, C. A., Jan Danser, A. H., Müller, D. N., Garrelds, I. M., Gasc, J.-M., Popova, E., Plehm, R., Peters, J., Bader, M., & Nguyen, G. (2006) · Hypertension · doi:10.1161/01.hyp.0000199912.47657.04 · Cited by 221
Human Prorenin Has “Gate and Handle” Regions for Its Non-proteolytic Activation
Suzuki, F., Hayakawa, M., Nakagawa, T., Nasir, U. M., Ebihara, A., Iwasawa, A., Ishida, Y., Nakamura, Y., & Murakami, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302579200 · Cited by 185
Self-citationNabi, A. H. M. N., Kageshima, A., Uddin, M. N., Nakagawa, T., Park, E. Y., & Suzuki, F. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.3.483 · Cited by 156
Self-citationKaneshiro, Y., Ichihara, A., Takemitsu, T. Y., Sakoda, M., Suzuki, F., Nakagawa, T., Hayashi, M., & Inagami, T. (2006) · Kidney International · doi:10.1038/sj.ki.5001627 · Cited by 151
Self-citationContribution of Nonproteolytically Activated Prorenin in Glomeruli to Hypertensive Renal Damage
Ichihara, A., Kaneshiro, Y., Takemitsu, T. Y., Sakoda, M., Nakagawa, T., Nishiyama, A., Kawachi, H., Shimizu, F., & Inagami, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121278 · Cited by 150
Self-citationNishiyama, A., Seth, D. M., & Navar, L. G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000026610.48842.cb · Cited by 103
Self-citationIchihara, A., Imig, J. D., Inscho, E. W., & Navar, L. G. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.4.f605 · Cited by 92
Self-citationNovel Integrative Approaches to the Identification of Candidate Genes in Hypertension
Hubner, N., Yagil, C., & Yagil, Y. (2006) · Hypertension · doi:10.1161/01.hyp.0000197951.82190.c4 · Cited by 90
Cheng, J., Encarnación, M. M. D., Warner, G. M., Gray, C., Nath, K. A., & Grande, J. P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00153.2005 · Cited by 80
Liu, S., Liang, Y., Huang, H.-C., Wang, L., Li, Y., Li, J., Li, X., & Wang, H. (2005) · Cellular Physiology and Biochemistry · doi:10.1159/000089846 · Cited by 38
Suzuki, F., Nakagawa, T., Kakidachi, H., Murakami, K., Inagami, T., & Nakamura, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1997 · Cited by 28
Self-citation
Cited by
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
Bader, M. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105610 · Cited by 345
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Zhang, Z., Sun, L., Wang, Y., Ning, G., Minto, A. W., Kong, J., Quigg, R. J., & Li, Y. C. (2008) · Kidney International · doi:10.1038/sj.ki.5002572 · Cited by 305
Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease
Siragy, H. M., & Carey, R. M. (2010) · American Journal of Nephrology · doi:10.1159/000313363 · Cited by 293
The Biology of the (Pro)Renin Receptor
Nguyen, G., & Muller, D. N. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009030300 · Cited by 220
Metadata
- Authors
- Kaneshiro, Y., Ichihara, A., Sakoda, M., Takemitsu, T., Nabi, A. H. M. N., Uddin, M. N., Nakagawa, T., Nishiyama, A., Suzuki, F., Inagami, T., & Itoh, H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-06
- Volume
- 18
- Issue
- 6
- Pages
- 1789-1795
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2139181447
- Cited by
- 256
- References
- 18
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.